DE-RESTRICT: Deimplementing Activity Restriction for Preterm Birth Prevention
University of Pennsylvania · with Foundation for SMFM, American Association of Obstetricians and Gynecologists Foundation (AAOGF) · NCT07698483
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 237
- US sites recruiting
- 2
- Study start
- July 16, 2026
- Record last updated
- August 10, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
DE-RESTRICT is a pilot study testing whether a strategy to reduce the use of activity restriction and bedrest in pregnancy is acceptable, appropriate, and feasible for prenatal care providers, and whether it changes how often activity restriction is recommended. Activity restriction and bedrest are commonly advised to try to prevent preterm birth, but they do not prevent it and may cause harm, and national guidelines recommend against them. The study takes place at two prenatal care settings within one health system and unfolds across four periods. In the pre-deimplementation period the study team develops a local clinical guideline and measures baseline outcomes. In the run-in period most provider education is delivered through interactive sessions with feedback, and audit and feedback begins. In the maintenance period audit and feedback continues. In the post-deimplementation period audit and feedback continues and outcomes are measured again. The study measures provider acceptability, appropriateness, and feasibility, the rate of activity restriction recommendations, patient-reported wellbeing and care experience, and the preterm birth rate.
Being studied: Multicomponent deimplementation strategy
Conditions: Preterm Birth; Activity Restriction; Bed Rest; Low-Value Care
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- For Providers: Physicians, midwives, physician assistants, nurse practitioners, nurses, nursing assistants, medical assistants, and other healthcare staff who provide or participate in prenatal or high-risk pregnancy care or consultation at a participating site.
- For Patients: Secondary patient-reported outcomes draw on pregnant individuals at high risk for preterm birth (qualifying diagnoses include short cervix, cervical insufficiency, multiple gestation, preterm labor, preterm contractions, vaginal bleeding, placental conditions, or a history of prior preterm birth), between 0 and 12 weeks postpartum for the survey measures. The activity restriction recommendation measure is collected through the Take Home Electronic Assessment (THEA) and therefore reaches only patients enrolled in THEA, at 33 weeks of gestation, across all periods; in the pre-deimplementation and post-deimplementation periods the additional survey battery is sent only to patients with a qualifying high-risk diagnosis.
Exclusion Criteria
- For Providers: Staff who self-exclude by choosing not to interact with deimplementation meetings and communications
- For Patients: Patients are excluded if they are unable to walk or are hospitalized without discharge home before delivery after the qualifying diagnosis is made.
Recruiting US locations
Hospital of the University of Pennsylvania
Philadelphia, PA 19104
Site contact: Beth L Pineles, MD, PhD · Beth.Pineles@Pennmedicine.upenn.edu
Pennsylvania Hospital
Philadelphia, PA 19107
Site contact: Beth L Pineles, MD, PhD · Beth.Pineles@Pennmedicine.upenn.edu
Study contacts (from the official record)
- Beth Pineles, MD, PhD · 267-283-8210 · Beth.Pineles@Pennmedicine.upenn.edu
- Kelli Jackson · Kelli.Jackson@PennMedicine.upenn.edu
Similar studies in Pennsylvania
All pregnancy studies in Pennsylvania →- RecruitingHealthy volunteers
Non-Invasive Preeclampsia Screening and Biobank
Sequenom, Inc.
- Location
- Philadelphia, PA + 15 other US sites
- Eligibility basics
- Ages 18+ · Women only
- RecruitingHealthy volunteers
Rezdiffra Pregnancy and Lactation Registry
Madrigal Pharmaceuticals, Inc.
- Location
- West Conshohocken, PA
- Eligibility basics
- Any age listed · Women only
- RecruitingHealthy volunteers
Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)
Sanofi Pasteur, a Sanofi Company
- Location
- Swiftwater, PA
- Eligibility basics
- Any age listed
- RecruitingPhase 3
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
Aerogen Pharma Limited
- Location
- Pittsburgh, PA + 17 other US sites
- Eligibility basics
- Any age listed